Skip to content
ApprovedFDA approvedStrong evidence

Brivaracetam

Prescription anti-epileptic medicine for focal seizures; it belongs to the racetam family but is not a lifestyle nootropic.

NootropicRacetamAntiseizure medicationRacetamNeuroprotectionGlutamateGABA

Pharmacology

ClassRacetam · Neuroprotection
Primary targetHigh-affinity ligand of synaptic vesicle protein SV2A
Targets3 receptor targets
Half-life~9 h
Onset~1 h
EvidenceStrong evidence
Affected systemsGlutamateGABA

Contents

DETAILED OVERVIEW

What is Brivaracetam?

Brivaracetam (brand name Briviact) is a prescription anti-epileptic medicine, approved in 2016 in the United States and the EU to treat focal, that is partial-onset, seizures. In the United States it is a controlled substance with a low risk of misuse (Schedule V). Chemically it belongs to the racetam family, but it is a serious medicine, not a lifestyle nootropic.

It binds to a brain protein called SV2A that takes part in signaling between nerve cells, more strongly than the related levetiracetam, and so reduces the excessive release of messenger substances that triggers seizures. Its effect starts quickly, and several large placebo-controlled studies have confirmed it. The most common side effects are drowsiness, dizziness and tiredness; irritability, anxiety, depression and aggression can also occur, and the prescribing information warns about suicidal thoughts, as for other anti-epileptic drugs. Stopping it suddenly can trigger seizures, and together with alcohol its sedating effect adds up.

Mechanism

Selective high-affinity SV2A ligand

Half-life

~9 h

Onset

~1 h (fast CNS entry)

Legal status

Rx (FDA/EMA); US Schedule V

Receptor profile

  • SV2A synaptic vesicle proteinStrong
  • Presynaptic neurotransmitter releaseModerate
  • Neuronal voltage-gated sodium channelsWeak

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Somnolence and sedation, the most common adverse effect, especially early in treatment
  • Dizziness and balance disturbance, dose-dependent
  • Fatigue and lethargy
  • Nausea and vomiting, mild gastrointestinal discomfort
  • Psychiatric and behavioral reactions: irritability, anxiety, depression, aggression
  • Coordination difficulties and unsteady gait, at higher doses

Contraindications · 6

  • Hypersensitivity to brivaracetam or levetiracetam
  • Pregnancy and breastfeeding: limited data, only under specialist supervision
  • Suicidal ideation or psychiatric history: antiepileptic class warning, close monitoring
  • Hepatic impairment: dose reduction required (hepatic metabolism)
  • Do not stop abruptly: withdrawal seizure risk, gradual tapering is required
  • Alcohol and CNS depressants: additive sedation and psychomotor impairment

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Brivaracetam is a prescription, officially approved medication used to reduce the frequency of epileptic seizures, specifically focal (partial-onset) seizures, either alone or alongside other medications. It acts quickly and is generally well tolerated compared to older similar drugs. Researchers are also looking into possible neuroprotective and cognitive effects, but that's still research interest, not an approved use.

Telegram

Have a question about Brivaracetam?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC11H20N2O2
UpdatedOctober 13, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.